אודות פרק זה
Join Leone Atkinson, Fortrea’s Executive Medical Director of Neuroscience and Ophthalmology, and Dr. John Huffaker from the Neuropsychiatric Research Center as they discuss the evolving landscape of Alzheimer’s clinical trials. Explore challenges in patient recruitment and retention, the role of caregivers, and how digital tools and AI are transforming at-home data collection. Learn why collaboration between CROs, sponsors, and research sites is key to advancing patient-centric trial design and improving outcomes.
אנגלית
ארצות הברית
תעתיק 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
חיפוש פרקים ישנים
חפש פרקים קודמים של Cortex Conversations: Insights in Neuroscience.
פרקים אחרים בפודקאסט הזה
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology, Fortrea
Robin Wolz, Chief Scientific Officer at Ixico
Description: This episode features an insightful interview be…
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Joanie Brown, Head of Operations at our Rapid Development Studio AI/ML, Fortrea
Mark Austin, Chief Technology Officer at Ixico
Description: In this episode of the Fortrea neuroscience podcast, …
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Abby Fuller, Senior Director of Strategic Delivery Growth in Neuroscience, Fortrea
Walter Gonzalez, Associate Director, Digital Health and Innovation, Fortrea
Haiyan Wei, SVP of Technology and …
Host: Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology at Fortrea
Participants:
Leone Atkinson, Executive Medical Director of Neuroscience and Ophthalmology at Fortrea
Alicia Baker, Vice President, Head of Global Regulatory Strategy at Fortrea
Description: Digital endpoints…
הצהרה: הפודקאסט והגרפיקה המוטבעים בדף זה הם מ-Fortrea, שהוא רכושו של בעליו ואינו קשור או מאושר על ידי Listen Notes, Inc.
